The goal of Tumor Immunology Training Program (TITP) is to prepare predoctoral students for a career in the application of immunological approaches to the diagnosis, prevention and treatment of cancer. Future scientific leaders in tumor immunology must not only be well-trained immunologists, they must also be able to appreciate the challenges in applying basic immunology techniques to clinically relevant questions. Toward that end the TITP stresses the importance of the development of translational research programs and encourages the interaction of pre-clinical and clinical research programs vital to the training of successful graduates. The TITP provides trainees with an advanced broad-based education with opportunities for focused training in all aspects of tumor immunology including translational aspects. The uniqueness of this training program is further augmented by the integration of an academic program comprised of diverse faculty within the setting of a world-renowned, NCI-designated, Comprehensive Cancer Center. Trainees are exposed to a broad perspective of cancer-related issues including cancer incidence and survival, the spectrum of scientific approaches to cancer and the realities of patient care. Furthermore, the training experience TITP students receive is augmented by the close proximity of Roswell Park Cancer Institute to the State University of New York at Buffalo. The primary mission of the proposed training grant is to support students during their second year of graduate study. During this time the students complete their didactic course requirements and laboratory rotations, select a Thesis Advisor and Thesis Advisory committee, prepare a research proposal and take a preliminary examination for advancement to candidacy. The requested training grant funds cover stipends and tuition costs for 4 predoctoral students per year. The Thesis Advisor assumes responsibility for financial support of the student beginning in the third year of study and continuing through completion of the degree. Students who successfully complete this training program will be well versed in all aspects of tumor immunology and will have the background necessary to establish clinically relevant research laboratories designed toward the development of novel therapies that are able to counteract tumor escape mechanisms.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA085183-10
Application #
8134020
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
2000-04-01
Project End
2013-08-31
Budget Start
2011-09-01
Budget End
2013-08-31
Support Year
10
Fiscal Year
2011
Total Cost
$133,450
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Szender, J Brian; Emmons, Tiffany; Belliotti, Sarah et al. (2017) Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study. Gynecol Oncol 146:491-497
Twum, Danielle Y F; Burkard-Mandel, Lauren; Abrams, Scott I (2017) The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease. J Leukoc Biol 102:307-315
Netherby, Colleen S; Abrams, Scott I (2017) Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease. Cancer Immunol Immunother 66:989-996
Leigh, Nicholas D; O'Neill, Rachel E; Du, Wei et al. (2017) Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function. J Immunol 199:336-347
Bucsek, Mark J; Qiao, Guanxi; MacDonald, Cameron R et al. (2017) ?-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy. Cancer Res 77:5639-5651
Netherby, Colleen S; Messmer, Michelle N; Burkard-Mandel, Lauren et al. (2017) The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production. J Immunol 198:4129-4139
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2017) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol :
Singel, Kelly L; Segal, Brahm H (2016) Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal. Immunol Rev 273:329-43
Singel, Kelly L; Segal, Brahm H (2016) NOX2-dependent regulation of inflammation. Clin Sci (Lond) 130:479-90
Fink, E E; Mannava, S; Bagati, A et al. (2016) Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells. Leukemia 30:104-11

Showing the most recent 10 out of 51 publications